Multinucleated giant cell formation exhibits features of phagocytosis with participation of the endoplasmic reticulum - PubMed (original) (raw)
Multinucleated giant cell formation exhibits features of phagocytosis with participation of the endoplasmic reticulum
Amy K McNally et al. Exp Mol Pathol. 2005 Oct.
Abstract
Macrophage fusion leading to formation of multinucleated giant cells during chronic inflammation is poorly understood in mechanism and physiological significance. To address this, we developed a system of human macrophage fusion that utilizes IL-4, IL-13, or alpha-tocopherol to generate large foreign body-type giant cells (FBGC). Extending our previously demonstrated requirements for F-actin and mannose receptor (MR) activity, we find that macrophage fusion exhibits further features of a phagocytic process. Pharmacological inhibition of IL-4-induced FBGC formation indicates critical roles for vacuolar-type ATPase, microtubules, the endoplasmic reticulum (ER), and calcium-independent phospholipase A(2) (iPLA(2)), but not calcium-dependent PLA(2) (cPLA(2)), secretory PLA(2) (sPLA(2)), cyclooxygenase, or lipoxygenase. Immunocytochemistry confirms iPLA(2) expression and absence of cPLA(2) or sPLA(2) expression in macrophages/FBGC. As markers of ER-mediated phagocytosis, calnexin and calregulin are detectable on non-permeabilized fusing macrophages and also concentrated at fusion interfaces where they co-localize with actin in permeabilized macrophages/FBGC. Furthermore, ER markers co-localize with concanavalin A reactivity on non-permeabilized fusing macrophages, suggesting that the ER may present MR ligand during fusion events. These data demonstrate for the first time that the mechanism of macrophage fusion leading to formation of multinucleated giant cells exhibits multiple features of phagocytosis with potential participation of the ER.
Similar articles
- Interleukin-4-induced macrophage fusion is prevented by inhibitors of mannose receptor activity.
McNally AK, DeFife KM, Anderson JM. McNally AK, et al. Am J Pathol. 1996 Sep;149(3):975-85. Am J Pathol. 1996. PMID: 8780401 Free PMC article. - Macrophage fusion and multinucleated giant cells of inflammation.
McNally AK, Anderson JM. McNally AK, et al. Adv Exp Med Biol. 2011;713:97-111. doi: 10.1007/978-94-007-0763-4_7. Adv Exp Med Biol. 2011. PMID: 21432016 Review. - Foreign body-type multinucleated giant cells induced by interleukin-4 express select lymphocyte co-stimulatory molecules and are phenotypically distinct from osteoclasts and dendritic cells.
McNally AK, Anderson JM. McNally AK, et al. Exp Mol Pathol. 2011 Dec;91(3):673-81. doi: 10.1016/j.yexmp.2011.06.012. Epub 2011 Jul 23. Exp Mol Pathol. 2011. PMID: 21798256 Free PMC article. - Disruption of filamentous actin inhibits human macrophage fusion.
DeFife KM, Jenney CR, Colton E, Anderson JM. DeFife KM, et al. FASEB J. 1999 May;13(8):823-32. doi: 10.1096/fasebj.13.8.823. FASEB J. 1999. PMID: 10224226 - Macrophage fusion: the making of osteoclasts and giant cells.
Vignery A. Vignery A. J Exp Med. 2005 Aug 1;202(3):337-40. doi: 10.1084/jem.20051123. J Exp Med. 2005. PMID: 16061722 Free PMC article. Review.
Cited by
- Absence of Pathogenic Mutations and Strong Association With HLA-DRB1*11:01 in Statin-Naïve Early-Onset Anti-HMGCR Necrotizing Myopathy.
Llansó L, Segarra-Casas A, Domínguez-González C, Malfatti E, Kapetanovic S, Rodríguez-Santiago B, de la Calle O, Blanco R, Dobrescu A, Nascimento-Osorio A, Paipa A, Hernandez-Lain A, Jou C, Mariscal A, González-Mera L, Arteche A, Lleixà C, Caballero-Ávila M, Carbayo Á, Vesperinas A, Querol L, Gallardo E, Olivé M. Llansó L, et al. Neurol Neuroimmunol Neuroinflamm. 2024 Sep;11(5):e200285. doi: 10.1212/NXI.0000000000200285. Epub 2024 Aug 6. Neurol Neuroimmunol Neuroinflamm. 2024. PMID: 39106428 Free PMC article. - Multinucleation resets human macrophages for specialized functions at the expense of their identity.
Ahmadzadeh K, Pereira M, Vanoppen M, Bernaerts E, Ko JH, Mitera T, Maksoudian C, Manshian BB, Soenen S, Rose CD, Matthys P, Wouters C, Behmoaras J. Ahmadzadeh K, et al. EMBO Rep. 2023 Mar 6;24(3):e56310. doi: 10.15252/embr.202256310. Epub 2023 Jan 4. EMBO Rep. 2023. PMID: 36597777 Free PMC article. - Pannexin1 channels-a potential therapeutic target in inflammation.
Rusiecka OM, Tournier M, Molica F, Kwak BR. Rusiecka OM, et al. Front Cell Dev Biol. 2022 Nov 9;10:1020826. doi: 10.3389/fcell.2022.1020826. eCollection 2022. Front Cell Dev Biol. 2022. PMID: 36438559 Free PMC article. Review. - PARP-inhibition reprograms macrophages toward an anti-tumor phenotype.
Wang L, Wang D, Sonzogni O, Ke S, Wang Q, Thavamani A, Batalini F, Stopka SA, Regan MS, Vandal S, Tian S, Pinto J, Cyr AM, Bret-Mounet VC, Baquer G, Eikesdal HP, Yuan M, Asara JM, Heng YJ, Bai P, Agar NYR, Wulf GM. Wang L, et al. Cell Rep. 2022 Oct 11;41(2):111462. doi: 10.1016/j.celrep.2022.111462. Cell Rep. 2022. PMID: 36223740 Free PMC article. - Multinucleated Giant Cells: Current Insights in Phenotype, Biological Activities, and Mechanism of Formation.
Ahmadzadeh K, Vanoppen M, Rose CD, Matthys P, Wouters CH. Ahmadzadeh K, et al. Front Cell Dev Biol. 2022 Apr 11;10:873226. doi: 10.3389/fcell.2022.873226. eCollection 2022. Front Cell Dev Biol. 2022. PMID: 35478968 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials